Use of Individual-level Covariates to Improve Latent Class Analysis of Trypanosoma cruzi Diagnostic Tests

Epidemiologic Methods

Volumn 1, Issue 1, 2012, Pages 32-54

  Tustin, Aaron W ^a   Small, Dylan S ^b   Delgado, Stephen ^c   Castillo Neyra, Ricardo ^d   Verastegui, Manuela R ^e   Ancca Juárez, Jenny M ^e   Quispe Machaca, Víctor R ^e   Gilman, Robert H ^d   Bern, Caryn ^f   Levy, Michael Z ^g  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chagas disease; latent class analysis; Trypanosoma cruzi

Indexed keywords

EID: 84902249584     PISSN: 21949263     EISSN: 2161962X     Source Type: Journal    
DOI: 10.1515/2161-962X.1005     Document Type: Article

References (40)

1. Akaike, H. (1974). A new look at the statistical model identification. IEEE Transactions on Automatic Control, 19:716–723.
2. Basáñez, M. G., Marshall, C., Carabin, H., Gyorkos, T. and Joseph L. (2004). Bayesian statistics for parasitologists. Trends in Parasitology, 20:85–91.
3. Bern, C., Verastegui, M., Gilman, R. H., Lafuente, C., Galdos-Cardenas, G., Calderon, M., Pacori, J., Del Carmen Abastoflor, M., Aparicio, H., Brady, M. F., Ferrufino, L., Angulo, N., Marcus, S., Sterling, C. and Maguire J. H. (2009). Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clinical Infectious Diseases, 49:1667–1674.
4. Blejer, J. L., Saguier, M. C. and Salamone, H. J. (2001). Antibodies to Trypanosoma cruzi among blood donors in Buenos Aires, Argentina. International Journal of Infectious Diseases, 5:89–93.
5. Branscum, A. J., Gardner, I. A. and Johnson, W. O. (2005). Estimation of diagnostic-test sensitivity and specificity through Bayesian modeling. Preventive Veterinary Medicine, 68:145-163.
6. Branscum, A. J., Johnson, W. O., Hanson, T. E. and Gardner, I. A. (2008). Bayesian semiparametric ROC curve estimation and disease diagnosis. Statistics in Medicine, 27:2474-2496.
7. Caballero, Z. C., Sousa, O. E., Marques, W. P., Saez-Alquezar, A. and Umezawa E. S. (2007). Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clinical and Vaccine Immunology, 14:1045-1049.
8. Campbell, D. A., Westenberger, S. J. and Sturm, N. R. (2004). The determinants of Chagas disease: connecting parasite and host genetics. Current Molecular Medicine, 4:549–562.
9. Centers for Disease Control and Prevention (2007). Blood donor screening for Chagas disease–United States, 2006-2007. MMWR Morbidity and Mortality Weekly Report, 56:141–143.
10. de Andrade, A. L., Zicker, F., de Oliveira, R. M., Almeida Silva, S., Luquetti, A., Travassos, L. R., Almeida, I. C., de Andrade, S. S., de Andrade, J. G. and Martelli C. M. (1996). Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet, 348:1407–1413.
11. Delgado, S., Castillo Neyra, R., Quispe Machaca, V. R., Ancca Juárez, J., Chou Chu, L., Verastegui, M. R., Moscoso Apaza, G. M., Bocángel, C. D., Tustin, A. W., Sterling, C. R., Comrie, A. C., Náquira, C., Cornejo del Carpio, J. G., Gilman, R. H., Bern, C. and Levy, M. Z. (2011). A history of Chagas disease transmission, control, and re-emergence in peri-rural La Joya, Peru. PLoS Neglected Tropical Diseases, 5:e970.
12. Dendukuri, N., Hadgu, A. and Wang, L. (2009). Modeling conditional dependence between diagnostic tests: a multiple latent variable model. Statistics in Medicine, 28:441–461.
13. Dendukuri, N. and Joseph, L. (2001). Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics, 57:158–167.
14. Efron, B. and Tibshirani, R. J. (1993). An Introduction to the Bootstrap. New York: Chapman & Hall.
15. Engel, B., Backer, J. and Buist, W. (2009). Journal of Agricultural, Biological, and Environmental Statistics, 15:83–100.
16. Goetghebeur, E., Liinev, J., Boelaert, M. and Van der Stuyft, P. (2000). Diagnostic test analyses in search of their gold standard: latent class analyses with random effects. Statistical Methods in Medical Research, 9:231–248.
17. Greenes, R. A. and Begg, C. B. (1985). Assessment of diagnostic technologies: methodology for unbiased estimation from samples of selectively verified patients. Investigative Radiology, 20:751–756.
18. Hadgu, A. and Qu, Y. (1998). A biomedical application of latent class models with random effects. Applied Statistics, 47:603–616.
19. Huang, G.-H. and Bandeen-Roche, K. (2004). Latent class regression with covariate effects on underlying and measured variables. Psychometrika, 69:5–32.
20. Hui, S. L. and Walter, S. D. (1980). Estimating the error rates of diagnostic tests. Biometrics, 36:167–171.
21. Johnson, W. O., Gastwirth, J. L. and Pearson, L. M. (2001). Screening without a “gold standard”: the Hui-Walter paradigm revisited. American Journal of Epidemiology, 153:921–924.
22. Johnson, W. O. and Hanson, T.E. (2005). Comment: On model expansion, model contraction, identifiability and prior information: two illustrative scenarios involving mismeasured variables. Statistical Science, 20:131–134.
23. Jones, G., Johnson, W. O. and Daan Vink, W. (2009). Evaluating a continuous biomarker for infection by using observed disease status with covariate effects on disease. Journal of the Royal Statistical Society, Series C (Applied Statistics), 58:705-717.
24. Joseph, L., Gyorkos, T. W. and Coupal, L. (1995). Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. American Journal of Epidemiology, 141:263–272.
25. Kirchhoff, L. V., Weiss, L. M., Wittner, M. and Tanowitz, H. B. (2004). Parasitic diseases of the heart. Frontiers in Bioscience, 9:706–723.
26. Kun, H., Moore, A., Mascola, L., Steurer, F., Lawrence, G., Kubak, B., Radhakr-ishna, S., Herron, R., Mone, T., Hunter, R. and Kuehnert, M. (2009). Transmission of Trypanosoma cruzi by heart transplantation. Clinical Infectious Diseases, 48:1534–1540.
27. Langhi Jr, D. M., Bordin, J. O., Castelo, A., Walter, S. D., Moraes-Souza, H. and Stumpf, R. J. (2002). The application of latent class analysis for diagnostic test validation of chronic Trypanosoma cruzi infection in blood donors. Brazilian Journal of Infectious Diseases, 6:181–187.
28. Levy, M. Z., Bowman, N. M., Kawai, V., Plotkin, J. B., Waller, L. A., Cabrera, L., Steurer, F., Seitz, A. E., Pinedo-Cancino, V. V., Cornejo del Carpio, J. G., Cordova Benzaquen, E., McKenzie, F. E., Maguire, J. H., Gilman, R. H. and Bern, C. (2009). Spatial patterns in discordant diagnostic test results for Chagas disease: links to transmission hotspots. Clinical Infectious Diseases, 48:1104–1106.
29. Lucas, C. M., Franke, E. D., Cachay, M. I., Tejada, A., Cruz, M. E., Kreutzer, R. D., Barker, D. C., McCann, S. H. and Watts, D. M. (1998). Geographic distribution and clinical description of leishmaniasis cases in Peru. American Journal of Tropical Medicine and Hygiene, 59:312–317.
30. Malchiodi, E. L., Chiaramonte, M. G., Taranto, N. J., Zwirner, N. W. and Margni, R. A. (1994). Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblot-ting and ELISA with a purified antigen (Ag163B6). Clinical and Experimental Immunology, 97:417–423.
31. Muench, H. (1959). Catalytic Models in Epidemiology. Cambridge, Massachusetts: Harvard University Press.
32. Nóbrega, A. A., Garcia, M. H., Tatto, E., Obara, M. T., Costa, E., Sobel, J. and Araujo, W. N. (2009). Oral transmission of Chagas disease by consumption of açaí palm fruit, Brazil. Emerging Infectious Diseases, 15:653–655.
33. Pirard, M., Iihoshi, N., Boelaert, M., Basanta, P., López, F. and Van der Stuyft, P. (2005). The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion, 45:554–561.
34. Qu, Y., Tan, M. and Kutner, M. (1996). Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. Biometrics, 52:797–810.
35. Staquet, M., Rozencweig, M., Lee, Y. J. and Muggia, F. M. (1981). Methodology for the assessment of new dichotomous diagnostic tests. Journal of Chronic Diseases, 34:599–610.
36. Tarleton, R. L., Reithinger, R., Urbina, J. A., Kitron, U. and Gürtler, R. E. (2007). The challenges of Chagas disease–grim outlook or glimmer of hope? PLoS Medicine, 4:e332.
37. Verani, J. R., Seitz, A., Gilman, R. H., LaFuente, C., Galdos-Cardenas, G., Kawai, V., de LaFuente, E., Ferrufino, L., Bowman, N. M., Pinedo-Cancino, V., Levy, M. Z., Steurer, F., Todd, C. W., Kirchhoff, L. V., Cabrera, L., Verastegui, M. and Bern, C. (2009). Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. American Journal of Tropical Medicine and Hygiene, 80:410–415.
38. Walter, S. D. and Irwig, L. M. (1988). Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. Journal of Clinical Epidemiology, 41:923–937.
39. World Health Organization (2004). The world health report 2004: changing history. Available at: http://www.who.int/whr/2004/en/. Accessed March 3, 2010.
40. Young, C., Losikoff, P., Chawla, A., Glasser, L. and Forman, E. (2007). Transfusion-acquired Trypanosoma cruzi infection. Transfusion, 47:540–544.